ADC Therapeutics SA (ADCT)
NYSE: ADCT · Pharmaceutical Preparations · Epalinges, CH · filing with the SEC since 2019
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Report filed | Mar 10, 2026 | Mar 27, 2025 | Mar 13, 2024 | Mar 15, 2023 | Mar 17, 2022 |
| Revenue | 81,357 | 70,837 | 69,558 | 209,908 | · |
| Cost of revenue | 5,798 | 5,949 | 2,529 | 3,301 | · |
| Research and development | 104,005 | 109,633 | 127,127 | 186,457 | · |
| Sales and marketing | 43,374 | 44,015 | 57,464 | 69,052 | · |
| General and administrative | 36,559 | 41,894 | 48,424 | 74,442 | · |
| Total costs and expenses | 202,856 | 201,491 | 235,544 | 333,252 | · |
| Operating income | -121,499 | -130,654 | -165,986 | -123,344 | · |
| Interest expense | 51,633 | 50,211 | 46,325 | 36,731 | · |
| Interest and investment income | 8,810 | 12,272 | 10,540 | 2,568 | · |
| Share of profit of equity-method investments | 0 | -1,544 | -5,528 | -10,084 | · |
| Other income (expense), net | 22,714 | 12,457 | 6,352 | 52,804 | · |
| Total non-operating income (expense) | -20,109 | -25,482 | -29,433 | -23,473 | · |
| Income before income taxes | -141,608 | -156,136 | -195,419 | -146,817 | · |
| Income tax expense | 1,015 | 166 | 39,106 | 227 | · |
| Net income | -142,623 | -157,846 | -240,053 | -157,128 | · |
| Earnings per share, basic | -1.12 | -1.62 | -2.94 | -2.01 | · |
| Earnings per share, diluted | -1.12 | -1.62 | -2.94 | -2.01 | · |
| Weighted average shares, basic | 127,067,540 | 97,159,966 | 81,712,166 | 78,152,964 | · |
| Weighted average shares, diluted | 127,067,540 | 97,159,966 | 81,712,166 | 78,152,964 | · |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenuesCost of revenue what it cost to make or buy what it sold
us-gaap:CostOfRevenueResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseSales and marketing the cost of finding and serving customers
us-gaap:SellingAndMarketingExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal costs and expenses every operating cost, the cost of revenue included
us-gaap:CostsAndExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest expense what its borrowing cost
us-gaap:InterestExpenseNonoperating
us-gaap:InterestExpenseInterest and investment income what its cash and investments earned
us-gaap:InvestmentIncomeInterestShare of profit of equity-method investments its share of companies it partly owns
us-gaap:IncomeLossFromEquityMethodInvestmentsOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding